Results 231 to 240 of about 12,042,484 (342)

Correction: Cardiac Troponin T (TNNT2) plays a potential oncogenic role in colorectal carcinogenesis. [PDF]

open access: yesCancer Cell Int, 2023
Liu Y   +7 more
europepmc   +1 more source

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation☆

open access: yesArchives of Biochemistry and Biophysics, 2016
A. Messer   +8 more
semanticscholar   +1 more source

Current and novel biomarkers in cardiogenic shock

open access: yesEuropean Journal of Heart Failure, EarlyView.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko   +5 more
wiley   +1 more source

55 High-sensitivity cardiac troponin T and risk of hypertension

open access: yesCirculation, 2015
J. McEvoy   +11 more
semanticscholar   +1 more source

Furosemide‐hydration matching with RenalGuard® in decompensated heart failure: an alternative way to use diuretics and saline

open access: yes
ESC Heart Failure, EarlyView.
Massimo Mapelli   +9 more
wiley   +1 more source

End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)

open access: yesEuropean Journal of Heart Failure, EarlyView.
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy